Schäfer, JuliaUniversität HeidelbergHeidelberg
Refine publication list
Year of publication
Type of Publication
Language
Co-author (Univ. of Heidelberg)
Publications in heiBIB 
- Schäfer, Julia: Bosentan enhances in vitro bortezomib's anti-proliferative potency against multiple myeloma by mechanisms going beyond endothelin receptor blockade / Julia Schäfer, Johanna Weiss, Dirk Theile, 2019. - 4 S.
In: British journal of haematology, ISSN 1365-2141. 184(2019), 6, Seite 1052-1055
DOI: 10.1111/bjh.15241
- Schäfer, Julia: Elucidating the beneficial effects of melphalan, adriamycin, and corticoids in combination with bortezomib against multiple myeloma in vitro / Julia Schäfer, Jürgen Burhenne, Johanna Weiss, Dirk Theile, 2019. - 6 S.
In: Naunyn-Schmiedeberg's archives of pharmacology, ISSN 1432-1912. 392(2019), 4, Seite 461-466
DOI: 10.1007/s00210-018-01602-1
- Schäfer, Julia: Cellular effect and efficacy of carfilzomib depends on cellular net concentration gradient / Julia Schäfer, Lukas Welti, Anja Seckinger, Jürgen Burhenne, Dirk Theile, Johanna Weiss, 12 May 2017. - 9 S.
In: Cancer chemotherapy and pharmacology, ISSN 1432-0843. 80(2017), 1, Seite 71-79
DOI: 10.1007/s00280-017-3335-4
- Clemens, Jannick: Bortezomib, carfilzomib and ixazomib do not mediate relevant transporter‑based drug‑drug interactions / Jannick Clemens, Lukas Welti, Julia Schäfer, Anja Seckinger, Jürgen Burhenne, Dirk Theile and Johann… . - 8 S.
In: Oncology letters, ISSN 1792-1082. 14(2017), 3, S. 3185-3192
DOI: 10.3892/ol.2017.6560
- Dettmer, Susan: Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell lines / Susan Dettmer, Dirk Theile, Julia Schäfer, Anja Seckinger, Jürgen Burhenne, Johanna Weiss. - 11 S.
In: Naunyn-Schmiedeberg's archives of pharmacology, ISSN 1432-1912. 389(2016), 10, S. 1091-1101
DOI: 10.1007/s00210-016-1276-9
